About Irit Rappley
Irit Rappley is a director at ALZpath.
Experience
This experience comes from Irit Rappley's profile and from SEC filings. For roles taken from filings, the years are when the filings name Irit Rappley in the role, so the role may have started earlier or lasted longer.
TR
The Michael J. Fox Foundation for Parkinson's Research Current
Co-Chair (Advisor), OGA Team, Targets To Therapies Initiative
2025 – Present
OS
Other Stuff Strategies Current
Independent Consultant
2024 – Present
AL
Alleo Labs Current
Member, Scientific Advisory Board
2024 – Present
ALZpath, Inc. Current
Member, Board of Directors
2023 – Present · Carlsbad, CA
Licenses an antibody to diagnostic companies for use in Alzheimer's blood tests.
TO
Teal Omics
Chief Scientific Officer
2024
RE
Recursion
VP Neuroscience and Translational Research
2021 – 2023
BS
Bristol Myers Squibb
Scientific Director, Discovery and Translational Research, Neuroscience TRC
2019 – 2021
CE
Celgene
Protein Homeostasis Lead for Neuroscience
2014 – 2019
TI
The Scripps Research Institute
Postdoctoral Research Associate
2009 – 2014
BH
Brigham and Women's Hospital
Postdoctoral Research Associate
2009
Key Colleagues at Startups
The people Irit Rappley works with at each company, as listed on that company's latest Form D.
ALZpath, Inc. · Form D, Jul 21, 2026
SH
Samantha Haeberlein
Director
Michael Banville
CEO and President
Harry Johns
Director
John Courtney
Director
John Hensing
Director
Jerre Stead
Co-Founder, Chair